Product
BR1019
2 clinical trials
4 indications
Indication
Type 2 Diabetes MellitusIndication
HypertensionIndication
Diabetes MellitusIndication
Type 2Clinical trial
A Randomized, Open-label, Single Dose, Two-way Replicate Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2" in Healthy VolunteersStatus: Completed, Estimated PCD: 2024-03-31
Clinical trial
A Randomized, Open-label, Multiple-dose, 6-sequence, 3-treatment, 3-period, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2023-06-29